Delivery Order SPE2DB24D2106-SPE2DB25FAVAP
Award Date
4/15/25
Potential Completion Date
4/16/25
Potential Value
$4.4K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $5,762.08, is for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a pharmaceutical product. The award has a firm fixed-price pricing type and a completion date of May 2, 2024. This order is issued under a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,440.52 contract is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a specialized pharmaceutical product. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the DLA...
This is a $4,321.56 firm fixed-price delivery order contract awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., a woman-owned small business organization. The contract is to provide VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a completion date of March 4, 2024. DMS Pharmaceutical Group holds a broader indefinite delivery contract with the Defense Logistics Agency valued up to $4,999,999 through 2025, which enables the agency to issue delivery orders...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The contract is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.0.5 ML, with a completion date of March 6, 2024 and a potential value of $4,321.56. This delivery order is part of a larger indefinite delivery contract, contract 4600082013 under the SPE2DB program, valued at up to $4,999,999 through the end of 2025. This...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide VAXNEUVANCE 0.5 ML SYRINGE 0.5ML. This $2,881.04 contract has a performance period running through May 13, 2024. The order is placed under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract with the DLA's Medical Supply Chain division, which supports recurring pharmaceutical and medical supply needs for military...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business, for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML. The firm fixed-price order has a potential value of $3,075.64 and a completion date of February 9, 2024. DMS Pharmaceutical Group holds an Indefinite Delivery Vehicle (IDV) contract, valued up to $4,999,999 through 2025, with DLA for the provision of a broad range of pharmaceutical products and...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML. The contract has a potential value of $6,345.88 and a completion date of February 6, 2024. This delivery order is issued against DMS Pharmaceutical Group's existing indefinite delivery contract 4600082013 with the Defense Logistics Agency under the SPE2DB program, valued at up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, with a firm fixed price of $28,810.40 and a completion date of March 1, 2024. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract 4600082013 with the...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) for the supply of 0.5 mL prefilled syringes of the pneumococcal vaccine VAXNEUVANCE. The $13,978.95 delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the DLA to issue orders for a comprehensive range...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,762.08 contract is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML. This order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, that allows the DLA to issue delivery orders for a comprehensive range of...